ALTOR BIOSCIENCE, LLC
CULVER CITY, CA

Altos BioScience, LLC is a clinical-stage biopharmaceutical company committed to creating advanced immunotherapies to tackle cancer and viral infections. Founded in 2002 by Dr. Hing C. Wong as a spin-off from Sunol Molecular Corporation (renowned as 'Sunol'), the company draws power from its unique engineered cytokine technology platforms, setting it apart in the biotech field. With financial backing from top-tier venture capital investors including Sanderling Ventures and TVM Capital, Altos BioScience is at the forefront of therapeutic innovation. The company has established itself with global roots, operating out of Florida while holding its incorporation roots in Delaware under status as a Foreign Qualification Corporation Limited (FORL) since December 11, 2017. Situated at 9920 Jefferson Blvd, Suite 1, Culver City, CA, USA, Altos BioScience is proactive about maintaining open lines of communication with stakeholders via phone numbers (954) 443-8600 and (954) 443-8610. For a deeper dive into its cutting-edge solutions, governance practices, and investor insights, one can visit their website at altorbioscience.com. Keeping in line with transparency, as of April 29, 2024, the company has made public its annual report for 2024 under Fei Number 30-0999738. Guided by esteemed leaders like CFO David Sachs, Altos BioScience is steadfastly driving forward groundbreaking treatments using its dual technology platforms. The company remains resolute in its mission to transform patient care and advance the science of healing.